Paper42864263PubMed
Gut microbiota shaping fatty liver disease progression.
Wysokińska M and 3 others. Life Sci Alliance, 2027.
Cite this record
ConductScience Library. Gut microbiota shaping fatty liver disease progression. Papers, record 42864263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42864263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gut microbiota shaping fatty liver disease progression.
- Journal
- Life Sci Alliance
- Year
- 2027
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-15
Source PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Fatty Liver | Major topic |
| Humans | |
| Animals | |
| Disease Progression | |
| Liver | |
| Intestinal Barrier Function | |
| Methylamines | |
| Lipid Metabolism | |
| Bacteria | |
| Bile Acids and Salts | |
| Fatty Acids, Volatile |
Source PubMed
References297
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41087898 | Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/41087898 | PubMed |
| 2 | 33894425 | Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis. | Cell Mol Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33894425 | PubMed |
| 3 | 22666356 | Citrulline a more suitable substrate than arginine to restore NO production and the microcirculation during endotoxemia. | PLoS One | 2012 | https://conductscience.org/library/papers/22666356 | PubMed |
| 4 | 28467925 | Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. | Cell Metab | 2017 | https://conductscience.org/library/papers/28467925 | PubMed |
| 5 | 22993202 | Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. | Gut | 2013 | https://conductscience.org/library/papers/22993202 | PubMed |
| 6 | 24278294 | Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. | PLoS One | 2013 | https://conductscience.org/library/papers/24278294 | PubMed |
| 7 | 24458110 | Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release. | Digestion | 2014 | https://conductscience.org/library/papers/24458110 | PubMed |
| 8 | 38298161 | Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease. | Gut Microbes | 2024 | https://conductscience.org/library/papers/38298161 | PubMed |
| 9 | 39746606 | Intrahepatic levels of microbiome-derived hippurate associates with improved metabolic dysfunction-associated steatotic liver disease. | Mol Metab | 2025 | https://conductscience.org/library/papers/39746606 | PubMed |
| 10 | 40055450 | Physical activity, diet, and social determinants of health associate with health related quality of life and fibrosis in MASLD. | Sci Rep | 2025 | https://conductscience.org/library/papers/40055450 | PubMed |
| 11 | 37364790 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature. | J Hepatol | 2023 | https://conductscience.org/library/papers/37364790 | PubMed |
| 12 | 16453106 | Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. | Cell Tissue Res | 2006 | https://conductscience.org/library/papers/16453106 | PubMed |
| 13 | 19359436 | Toll-like receptors as targets in chronic liver diseases. | Gut | 2009 | https://conductscience.org/library/papers/19359436 | PubMed |
| 14 | 38967596 | Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment. | Hepatol Commun | 2024 | https://conductscience.org/library/papers/38967596 | PubMed |
| 15 | 29563342 | Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. | JCI Insight | 2018 | https://conductscience.org/library/papers/29563342 | PubMed |
| 16 | 38992851 | Amplifying hepatic L-aspartate levels suppresses CCl4-induced liver fibrosis by reversing glucocorticoid receptor β-mediated mitochondrial malfunction. | Pharmacol Res | 2024 | https://conductscience.org/library/papers/38992851 | PubMed |
| 17 | 30120222 | Microbial tryptophan catabolites in health and disease. | Nat Commun | 2018 | https://conductscience.org/library/papers/30120222 | PubMed |
| 18 | 34002097 | UCP1 governs liver extracellular succinate and inflammatory pathogenesis. | Nat Metab | 2021 | https://conductscience.org/library/papers/34002097 | PubMed |
| 19 | 28550049 | Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. | Gut | 2018 | https://conductscience.org/library/papers/28550049 | PubMed |
| 20 | 27041637 | CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells. | Cell Mol Immunol | 2017 | https://conductscience.org/library/papers/27041637 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42864263
GET https://conductscience.org/api/papers/v1/42864263/references?page=2